AlphaCentric Advisors »

Xeris Pharmaceuticals shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $341k 43k 7.85

More positions owned by AlphaCentric Advisors

Gilead Sciences (GILD)
Invitation Homes (INVH)
Ishares Tr Mbs Etf (MBB)
Euronet Worldwide (EEFT)
Vertex Pharmaceuticals Incorporated (VRTX)
Astrazeneca Sponsored Adr
Alpine Income Ppty Tr (PINE)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Ishares Tr Rus 1000 Val Etf (IWD)
Ionis Pharmaceuticals (IONS)
Stereotaxis Com New (STXS)
Incyte Corporation (INCY)
Insmed Com Par $.01 (INSM)
AMREP Corporation (AXR)
Argenx Se Sponsored Adr (ARGX)

View all positions for AlphaCentric Advisors

Top funds holding Xeris Pharmaceuticals

BlackRock
Vanguard Group
D. E. Shaw & Co
Geode Capital Management
State Street Corporation
Qube Research & Technologies
Nuveen
Driehaus Capital Management
Rosalind Advisors
Parkman Healthcare Partners
Two Sigma Investments
Goldman Sachs Group
Charles Schwab Investment Management
Legal & General Group
CenterBook Partners

View all funds holding Xeris Pharmaceuticals